FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

The FDA approved a supplemental NDA for Tracleer (bosentan) submitted by Actelion Pharmaceuticals US, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Systemic Sclerosis

Drugs mentioned

• TRACLEER (bosentan)

Snippet

SUPPL AP for TRACLEER (BOSENTAN)